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The aim of this study was to evaluate whether diagnosing pulmonary fibrosis with projection 
radiography can be improved by using X-ray dark-field radiograms. Pulmonary X-ray transmission 
and dark-field images of C57Bl/6N mice, either treated with bleomycin to induce pulmonary fibrosis 
or PBS to serve as controls, were acquired with a prototype grating-based small-animal scanner. Two 
blinded readers, both experienced radiologists and familiar with dark-field imaging, had to assess 
dark-field and transmission images for the absence or presence of fibrosis. Furthermore readers were 
asked to grade their stage of diagnostic confidence. Histological evaluation of the lungs served as the 
standard of reference in this study. Both readers showed a notably higher diagnostic confidence when 
analyzing the dark-field radiographs (p < 0.001). Diagnostic accuracy improved significantly when 
evaluating the lungs in dark-field images alone (p = 0.02) or in combination with transmission images 
(p = 0.01) compared to sole analysis of absorption images. Interreader agreement improved from 
good when assessing only transmission images to excellent when analyzing dark-field images alone 
or in combination with transmission images. Adding dark-field images to conventional transmission 
images in a murine model of pulmonary fibrosis leads to an improved diagnosis of this disease on chest 
radiographs.
In pulmonary fibrosis, healthy lung tissue is destroyed and replaced by connective tissue1,2. The diagnosis of fibro-
sis remains challenging using conventional X-ray imaging, especially in early and moderate stages of the disease: 
As the density of air-filled lung tissue is rather small, mainly severe changes in tissue structure due to scarring and 
atelectasis, as they appear in pulmonary fibrosis, might lead to a visible increase of absorption signal intensity in 
conventional transmission images3–5.
X-ray dark-field radiography visualizes the small-angle scattering of X-rays at tissue-air interfaces6–8. As healthy 
pulmonary tissue yields an exceedingly strong dark-field signal, even small changes in lung structure, for example 
due to emphysema, lead to a significant decrease in signal strength9,10. As a result this may make dark-field imaging 
more convenient for the detection of pulmonary diseases compared to transmission radiography11.
Dark-field images are acquired by introduction of a three grating Talbot-Lau interferometer into the X-ray 
beam, where one grating is placed between the X-ray source and the sample and another two gratings are 
mounted between the sample and the detector. Images are gained while moving one of the gratings perpen-
dicularly to the beam propagation direction over one grating period. Conventional transmission, differential 
phase-contrast and dark-field images are obtained from the recorded pictures by applying Fourier analysis12–14.
Since so far the diagnostic value of dark field imaging was evaluated for pulmonary emphysema11, the aim 
of the presented reader study was to investigate whether this technology offers incremental diagnostic value for 
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diagnosing fibrosis in vivo compared to conventional X-ray imaging. The results of this reader study emphasize 
the superiority of dark field over transmission imaging as diagnostic accuracy, interreader agreement as well as 
diagnostic confidence significantly increase when assessing dark-field images.
Results
Quantitative Histology. Since histology showed that the lungs of 7 animals which had received bleomycin 
did not show any signs of fibrosis, these mice were considered non responders and excluded from the study.
Tissue quantification of the remaining lungs proved that the animals in the experimental group had devel-
oped lung fibrosis. Examples of a healthy and a fibrotic lung in transmission and dark-field imaging as well as 
the underlying histology are depicted in Fig. 1. Tissue percentage of the lungs in the experimental group was 
54.1 ± 10.5% compared to a tissue percentage of 36.0 ± 3.1% in the control group (p < 0.001).
Quantitative Image Analysis. No significant change in absorption signal intensities was observed between 
healthy and fibrotic lungs (0.638 ± 0.04 for control lungs, 0.673 ± 0.08 for fibrotic lungs; p = 0.18) (Fig. 2A).
By contrast, mean dark-field signal intensity of the healthy controls was 1.49 ± 0.12. Lungs of the animals in 
the fibrosis group showed a significantly decreased signal intensity (0.725 ± 0.23; p < 0,001) (Fig. 2B).
Reader Study. Diagnostic accuracy. Although both readers performed well when analyzing transmission 
images (area under the curve 0.9), a significant improvement in diagnostic accuracy was observed when assessing 
dark-field images, either alone (p = 0.02) or in combination with transmission images (p = 0.01), mainly due to a 
strong increase in sensitivity (Table 1).
Interreader agreement. Interreader agreement for transmission images was good, with a κ value of 0.72. When 
analyzing dark-field images alone or in combination with transmission images Cohen’s Kappa coefficient turned 
out to be excellent (Kappa value 0.93 for dark-field images; Kappa value 1.00 for dark-field combined with trans-
mission images).
Diagnostic confidence. Table 2 shows the mean values for diagnostic confidence indicated by both readers. 
Diagnostic confidences significantly increased for reader 1 (p < 0.0001) and reader 2 (p < 0.001) when analyzing 
dark-field images alone compared to the analysis of transmission images. Nevertheless, no further increase of 
diagnostic confidence could be observed when combining dark-field and transmission radiograms.
Figure 1. Dark-field and transmission images of fibrotic and healthy murine lungs. Representative pictures of a 
transmission image (left) and dark-field image (middle) of a healthy (upper row) and fibrotic lung (lower row). 
Histology (right) serves as the gold standard.
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Discussion
Although numerous promising, mostly computed tomography (CT)-based imaging approaches for the detection 
and characterization of chronic pulmonary diseases have emerged during the last few years15, standard chest 
radiography is still the most frequently used tool for diagnostic purposes concerning the lung. Due to its wide 
availability as well as short scanning times and easy handling, it remains the first diagnostic step for patients pre-
senting with symptoms of pulmonary disease16.
Unfortunately, due to its low sensitivity and specificity, a considerable number of diagnoses are missed in 
projection radiography17. Adding a highly sensitive new technique to this established imaging method might 
solve this problem.
Figure 2. Quantitative evaluation of absorption and dark-field signal intensities. Comparison of absorption 
signal intensities of healthy control lungs (white column) with fibrotic lungs (grey column) did not show 
a statistically significant difference (A). In the corresponding dark-field images fibrotic lungs showed a 
significantly decreased dark-field signal intensity compared to healthy lungs; *p < 0.001 (B).
Imaging 
modality
Sensitivity  
(95% Confidence Interval)
Specificity  
(95% Confidence Interval) AUC p-value*
Transmission 84.4 (67.2–94.7) 95.8 (78.9–99.9) 0.90
Dark field 96.9 (83.8–99.9) 100.0 (85.8–100.0) 0.98 0.02
Transmission 
and Dark-field 100.0 (89.1–100.0) 100.0 (85.8–100.0) 1.0 0.01
Table 1. Diagnostic accuracy for separate analysis of transmission and dark-field images as well as combined 
readings. AUC: Area Under the Curve. *Test for significance between transmission and dark-field readings or 
transmission and combined image analysis.
Diagnostic 
confidence Transmission
Dark 
field
Transmission and 
Dark field
Reader 1 1.6 ± 0.9 2.7 ± 0.5 2.7 ± 0.5
Reader 2 1.9 ± 0.8 2.7 ± 0.8 2.6 ± 0.8
Table 2. Diagnostic confidence indicated by reader 1 and reader 2 for interpretation of transmission and dark-
field images, either evaluated separately or combined.
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The results of our study indicate that dark-field imaging is a valuable tool to improve the diagnosis of fibrosis 
on projection images compared to conventional transmission-based radiographs alone. A stronger interreader 
agreement and a significantly improved diagnostic confidence as well as diagnostic accuracy were found.
These results are in accordance with the outcome of a previous reader study performed on pulmonary emphy-
sema, which found that when comparing the diagnostic value of X-ray dark-field imaging in detecting different 
stages of emphysema, a clear superiority over conventional transmission images could be observed11.
Histopathology served as the standard of reference for this study. Seven animals that had received bleomy-
cin did not show measurable histological signs of fibrosis and therefore needed to be excluded from the study. 
Quantitative signal analysis of the remaining lungs’ transmission and dark-field images yielded a faintly visible, 
but not significant increase in transmission signal intensities and a distinct decrease in dark-field signal intensi-
ties, indicating the presence of pulmonary fibrosis. These results are in good correlation with the signal analysis 
performed in a recently submitted proof-of-principle paper18.
As has previously been shown for pulmonary emphysema11 and fibrosis18 dark-field signal intensities show an 
excellent correlation with quantitative histology, which is due to the dark-field signal’s high sensitivity to morpho-
logical changes of lung tissue. Because conventional transmission images are less sensitive, especially to beginning 
alterations in lung tissues composition, it is widely accepted that diagnosing pulmonary fibrosis without the use 
of CT remains challenging19.
Therefore, the addition of morphological information provided by the dark-field signal to the transmission 
radiograms’ anatomical background, seems to be an excellent diagnostic tool. Combining the information readers 
obtain from both imaging modalities results in best diagnostic efficiency.
Compared to conventional clinical radiography without gratings, transmission images acquired with a 
grating-based radiography and similar X-ray parameters will lead to a slight decrease in SNR by a factor of about 
1.42 (√2) due to the presence of the G2 absorption grating in the beam20. In our fibrosis data, several readers 
confirmed that the image quality of the transmission images is excellent.
When thinking of the potential clinical application of the technique some challenges have to be addressed: 
So far, only small animal models such as mice can be used to perform dark-field imaging. Before transferring 
this new imaging method to a clinical setup, some technical developments are necessary: With an estimated 1.4 
mGy18 the image acquisition dose in our study is fully acceptable even to perform longitudinal studies in animals. 
Nonetheless, for a conventional imaging method it is still too high to be routinely used in a clinical environment. 
Therefore, improvement of dose efficiency is one major task that still needs to be solved. Moreover, a larger-field 
of view to transfer this imaging method from small-animal studies to human applications is needed. Thus larger 
gratings have to be developed. Finally, a switch to higher energies up to 125 kV as being used in conventional 
chest X-ray imaging is a necessary step as well.
To conclude, this study indicates that the combined reading of dark-field and transmission chest radiographs 
allows a reliable discrimination between diseased and healthy lungs in the presented murine model of pulmonary 
fibrosis.
Methods
Small animal protocol. Permission from the Institutional Animal Care and Use Committee was obtained 
before animal experiments, which followed national (Gesellschaft für Versuchstierkunde/Society of Laboratory 
Animals (GV-SOLAS)) and international (Federation of European Laboratory Animal Science Associations 
(FELASA)) animal welfare guidelines.
Pulmonary fibrosis was induced by instillation of 80 μl bleomycin (Sigma-Aldrich, Munich, Germany) dis-
solved in sterile phosphate-buffered saline (PBS) (3 U/kg body weight) in the trachea of pathogen-free, eight to 
ten week old, female C57BL/6 N mice (n = 23, Charles River Laboratories, Sulzfeld, Germany)21, whereas control 
mice (n = 12) received 80 μl sterile phosphate-buffered saline. All animals were sacrificed 14 days21 after applica-
tion of bleomycin or PBS and scanned immediately before the incidence. By using intraperitoneal injection of 
fentanyl (50 μg/kg body weight), midazolam (5 mg/kg body weight) and medetomidine (500 μg/kg body weight), 
mice were anesthetized for PBS/bleomycin application as well as image acquisition.
Post mortem lungs were filled with paraformaldehyde. After surgical extraction, the organs were placed into 
falcon tubes with paraformaldehyde for further processing.
Imaging Protocol. All animals were scanned in a prototype small-animal scanner22,23 that was equipped 
with a built-in fan to prevent the animals from cooling down. Furthermore, the mice’s respiratory frequency 
and body temperature were monitored while images were acquired. The anesthetized and freely breathing mice 
were placed in a supine position on the sample bed in the scanner, which was operated with five stepping posi-
tions (three seconds exposure time per stepping) of the source grating. The source ran at 35 kVp and 18 W. The 
field-of-view was round with a diameter of 5 cm and the spatial resolution in the sample plane was 60 μm. The 
scanner’s grating interferometer consists of three gratings: a gold source grating (period (p) = 10 μm, height 
(h) = 35 μm), a nickel phase grating (p = 3.24 μm, h = 4 μm; distance to source grating 30 cm) and a gold analyzer 
grating (p = 4.8 μm, h = 45 μm; distance to source grating 45 cm).
Histology. Upon washing the lungs in order to remove the paraformaldehyde, they were decalcified in 10% 
EDTA for five days. Afterwards, the organs were dehydrated and embedded in paraffin. At intervals of 0.5 mm 
multiple 10 μm slices were cut in the coronal plane. These sections were deparaffinized, hydrated, stained with 
Elastica van Gieson (EvG) and dehydrated again. Subsequently all slices were scanned at different magnification 
(MIRAX SCAN, Zeiss, Göttingen, Germany) to create digital images.
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Quantitative Morphometry. The histological slices of the lungs were analyzed with design-based stereol-
ogy using an Olympus BX51 (Olympus, Germany) light microscope equipped with a computer-assisted stereo-
logic toolbox (newCAST, Visiopharm, Hoersholm, Denmark). Slices of pulmonary tissue that covered the whole 
cross-section of the right and the left lung in coronal plane were evaluated. Within one of these slices 35 randomly 
selected regions of interest were analyzed by using a computer-aided system following published guidelines for 
tissue-quantification24. Tissue percentage, a marker for severity of fibrosis, was assessed by counting points hitting 
lung parenchymal tissue (Ptissue) or lung parenchymal air (Pair). The percentage volume was calculated by applying 
the formula
∑ ∑ ∑− = × + .Tissue % P 100/ P Ptissue tissue air
Quantitative Signal Analysis. In order to perform quantitative signal analysis, overlaying osseous struc-
tures (such as ribs and spine) were excluded. Signal intensities were then quantified using pentagonally shaped 
regions of interest (ROIs) that were placed manually into the images so that as much lung tissue as possible was 
captured, excluding the shadows of the mediastinum and diaphragm. The lungs of 5 animals in the control group 
and 10 animals in the group with fibrosis have been analyzed in a previous study using a distinct quantification 
algorithm18.
Reader Study. Lungs from a total of 28 mice (12 control mice, 16 mice in the fibrosis group) were analyzed. 
Each transmission image was assessed in isolation for the presence or absence of fibrosis by two blinded, inde-
pendent and experienced radiologists, familiar with dark-field imaging. Additionally, readers rated their grade 
of diagnostic confidence using a scale ranging from 0 (not confident), to 1 (moderately confident), 2 (quite con-
fident) and 3 (highly confident)25. After an interval of two weeks both radiologists assessed dark-field images for 
fibrosis in the same way, and another two weeks later, corresponding transmission and dark-field images were 
jointly analyzed for the presence of fibrosis. The two weeks intervals were enforced to minimize recall bias. As all 
images were handed over as Dicom files, the readers were free to adjust the window settings according to their 
preference.
Statistical Analysis. Diagnostic accuracy of readers’ visual interpretation of (a) transmission images alone, 
(b) dark-field images alone and (c) transmission and dark-field images combined was calculated using histo-
pathological proof of fibrosis development as the reference standard. To test for differences in diagnostic accuracy, 
the DeLong method was used26 whereas inter-reader agreement between the observers for the assessment of 
fibrosis was determined using Cohen’s Kappa coefficient. Levels of agreement on κ values were defined as follows: 
a κ value of less than 0.2, poor agreement; a κ value of 0.21–0.40, fair agreement; a κ value of 0.41–0.60, moderate 
agreement; a κ value of 0.61–0.80, good agreement; and a κ value of 0.81–1.00, very good agreement27. The diag-
nostic confidence ratings were compared between the three rounds of reading using t-test. MedCalc® (version 
15.2.2, Ostend, Belgium) was used as statistical software.
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